The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go to next?

Weeks, Andrew ORCID: 0000-0002-1909-337X (2015) The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go to next? BJOG: an International Journal of Obstetrics and Gynaecology, 122 (2). pp. 202-210.

Text BJOG PPH Review 2015_v122_p202.pdf - Unspecified Access to this file is embargoed until Unspecified. Download (185kB)

Abstract

Postpartum haemorrhage (PPH) remains a major cause of maternal deaths worldwide, and is estimated to cause the death of a woman every 10 minutes. This review presents the latest clinical advice, including new evidence on controlled cord traction, misoprostol, and oxytocin. The controversy around the diagnosis of PPH, the limitations of universal prophylaxis, and novel ways to provide obstetric first aid are also presented. It ends with a call to develop high-quality front-line obstetric services that can deal rapidly with unexpected haemorrhages as well as minimising blood loss at critical times: major abruption, placenta praevia, and caesarean for prolonged labour.

Item Type:	Article
Uncontrolled Keywords:	Maternal mortality, misoprostol, oxytocin, Postpartum Hemorrhage
Depositing User:	Symplectic Admin
Date Deposited:	25 Jan 2016 11:39
Last Modified:	16 Dec 2022 02:51
DOI:	10.1111/1471-0528.13098
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/2047827